First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Shaw, Alice T, Bauer, Todd M, de Marinis, Filippo, Felip, Enriqueta, Goto, Yasushi, Liu, Geoffrey, Mazieres, Julien, Kim, Dong-Wan, Mok, Tony, Polli, Anna, Thurm, Holger, Calella, Anna M, Peltz, Gerson, Solomon, Benjamin J
Published in The New England journal of medicine (19.11.2020)
Published in The New England journal of medicine (19.11.2020)
Get full text
Journal Article
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Solomon, Benjamin J, Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Tursi, Jennifer, Blackhall, Fiona
Published in The New England journal of medicine (04.12.2014)
Published in The New England journal of medicine (04.12.2014)
Get full text
Journal Article
Web Resource
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer
Jänne, Pasi A, Yang, James Chih-Hsin, Kim, Dong-Wan, Planchard, David, Ohe, Yuichiro, Ramalingam, Suresh S, Ahn, Myung-Ju, Kim, Sang-We, Su, Wu-Chou, Horn, Leora, Haggstrom, Daniel, Felip, Enriqueta, Kim, Joo-Hang, Frewer, Paul, Cantarini, Mireille, Brown, Kathryn H, Dickinson, Paul A, Ghiorghiu, Serban, Ranson, Malcolm
Published in The New England journal of medicine (30.04.2015)
Published in The New England journal of medicine (30.04.2015)
Get full text
Journal Article
Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma
Prat, Aleix, Navarro, Alejandro, Paré, Laia, Reguart, Noemí, Galván, Patricia, Pascual, Tomás, Martínez, Alex, Nuciforo, Paolo, Comerma, Laura, Alos, Llucia, Pardo, Nuria, Cedrés, Susana, Fan, Cheng, Parker, Joel S, Gaba, Lydia, Victoria, Iván, Viñolas, Nuria, Vivancos, Ana, Arance, Ana, Felip, Enriqueta
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
Herbst, Roy S, Giaccone, Giuseppe, de Marinis, Filippo, Reinmuth, Niels, Vergnenegre, Alain, Barrios, Carlos H, Morise, Masahiro, Felip, Enriqueta, Andric, Zoran, Geater, Sarayut, Özgüroğlu, Mustafa, Zou, Wei, Sandler, Alan, Enquist, Ida, Komatsubara, Kimberly, Deng, Yu, Kuriki, Hiroshi, Wen, Xiaohui, McCleland, Mark, Mocci, Simonetta, Jassem, Jacek, Spigel, David R
Published in The New England journal of medicine (01.10.2020)
Published in The New England journal of medicine (01.10.2020)
Get full text
Journal Article
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Gadgeel, Shirish, Rodríguez-Abreu, Delvys, Speranza, Giovanna, Esteban, Emilio, Felip, Enriqueta, Dómine, Manuel, Hui, Rina, Hochmair, Maximilian J, Clingan, Philip, Powell, Steven F, Cheng, Susanna Yee-Shan, Bischoff, Helge G, Peled, Nir, Grossi, Francesco, Jennens, Ross R, Reck, Martin, Garon, Edward B, Novello, Silvia, Rubio-Viqueira, Belén, Boyer, Michael, Kurata, Takayasu, Gray, Jhanelle E, Yang, Jing, Bas, Tuba, Pietanza, M Catherine, Garassino, Marina C
Published in Journal of clinical oncology (10.05.2020)
Published in Journal of clinical oncology (10.05.2020)
Get full text
Journal Article
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer
Solomon, Benjamin J, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Tang, Yiyun, Wilner, Keith D, Blackhall, Fiona, Mok, Tony S
Published in Journal of clinical oncology (01.08.2018)
Published in Journal of clinical oncology (01.08.2018)
Get full text
Journal Article
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Thress, Kenneth S, Paweletz, Cloud P, Felip, Enriqueta, Cho, Byoung Chul, Stetson, Daniel, Dougherty, Brian, Lai, Zhongwu, Markovets, Aleksandra, Vivancos, Ana, Kuang, Yanan, Ercan, Dalia, Matthews, Sarah E, Cantarini, Mireille, Barrett, J Carl, Jänne, Pasi A, Oxnard, Geoffrey R
Published in Nature medicine (01.06.2015)
Published in Nature medicine (01.06.2015)
Get full text
Journal Article
Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer
Wolf, Jürgen, Seto, Takashi, Han, Ji-Youn, Reguart, Noemi, Garon, Edward B, Groen, Harry J.M, Tan, Daniel S.W, Hida, Toyoaki, de Jonge, Maja, Orlov, Sergey V, Smit, Egbert F, Souquet, Pierre-Jean, Vansteenkiste, Johan, Hochmair, Maximilian, Felip, Enriqueta, Nishio, Makoto, Thomas, Michael, Ohashi, Kadoaki, Toyozawa, Ryo, Overbeck, Tobias R, de Marinis, Filippo, Kim, Tae-Min, Laack, Eckart, Robeva, Anna, Le Mouhaer, Sylvie, Waldron-Lynch, Maeve, Sankaran, Banu, Balbin, O. Alejandro, Cui, Xiaoming, Giovannini, Monica, Akimov, Mikhail, Heist, Rebecca S
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
Paik, Paul K, Felip, Enriqueta, Veillon, Remi, Sakai, Hiroshi, Cortot, Alexis B, Garassino, Marina C, Mazieres, Julien, Viteri, Santiago, Senellart, Helene, Van Meerbeeck, Jan, Raskin, Jo, Reinmuth, Niels, Conte, Pierfranco, Kowalski, Dariusz, Cho, Byoung Chul, Patel, Jyoti D, Horn, Leora, Griesinger, Frank, Han, Ji-Youn, Kim, Young-Chul, Chang, Gee-Chen, Tsai, Chen-Liang, Yang, James C.-H, Chen, Yuh-Min, Smit, Egbert F, van der Wekken, Anthonie J, Kato, Terufumi, Juraeva, Dilafruz, Stroh, Christopher, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jürgen, Heymach, John V, Le, Xiuning
Published in The New England journal of medicine (03.09.2020)
Published in The New England journal of medicine (03.09.2020)
Get full text
Journal Article
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Garon, Edward B, Rizvi, Naiyer A, Hui, Rina, Leighl, Natasha, Balmanoukian, Ani S, Eder, Joseph Paul, Patnaik, Amita, Aggarwal, Charu, Gubens, Matthew, Horn, Leora, Carcereny, Enric, Ahn, Myung-Ju, Felip, Enriqueta, Lee, Jong-Seok, Hellmann, Matthew D, Hamid, Omid, Goldman, Jonathan W, Soria, Jean-Charles, Dolled-Filhart, Marisa, Rutledge, Ruth Z, Zhang, Jin, Lunceford, Jared K, Rangwala, Reshma, Lubiniecki, Gregory M, Roach, Charlotte, Emancipator, Kenneth, Gandhi, Leena
Published in The New England journal of medicine (21.05.2015)
Published in The New England journal of medicine (21.05.2015)
Get full text
Journal Article
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial
Camidge, D Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James C H, Han, Ji-Youn, Hochmair, Maximilian J, Lee, Ki Hyeong, Delmonte, Angelo, García Campelo, Maria Rosario, Kim, Dong-Wan, Griesinger, Frank, Felip, Enriqueta, Califano, Raffaele, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Lin, Huamao M, Gupta, Neeraj, Hanley, Michael J, Ni, Quanhong, Zhang, Pingkuan, Popat, Sanjay
Published in Journal of clinical oncology (01.11.2020)
Published in Journal of clinical oncology (01.11.2020)
Get full text
Journal Article
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Reck, Martin, Luft, Alexander, Szczesna, Aleksandra, Havel, Libor, Kim, Sang-We, Akerley, Wallace, Pietanza, Maria Catherine, Wu, Yi-Long, Zielinski, Christoph, Thomas, Michael, Felip, Enriqueta, Gold, Kathryn, Horn, Leora, Aerts, Joachim, Nakagawa, Kazuhiko, Lorigan, Paul, Pieters, Anne, Kong Sanchez, Teresa, Fairchild, Justin, Spigel, David
Published in Journal of clinical oncology (01.11.2016)
Published in Journal of clinical oncology (01.11.2016)
Get full text
Journal Article
ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Shaw, Alice T, Solomon, Benjamin J, Besse, Benjamin, Bauer, Todd M, Lin, Chia-Chi, Soo, Ross A, Riely, Gregory J, Ou, Sai-Hong Ignatius, Clancy, Jill S, Li, Sherry, Abbattista, Antonello, Thurm, Holger, Satouchi, Miyako, Camidge, D Ross, Kao, Steven, Chiari, Rita, Gadgeel, Shirish M, Felip, Enriqueta, Martini, Jean-François
Published in Journal of clinical oncology (01.06.2019)
Published in Journal of clinical oncology (01.06.2019)
Get full text
Journal Article
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
Carbone, David P, Reck, Martin, Paz-Ares, Luis, Creelan, Benjamin, Horn, Leora, Steins, Martin, Felip, Enriqueta, van den Heuvel, Michel M, Ciuleanu, Tudor-Eliade, Badin, Firas, Ready, Neal, Hiltermann, T. Jeroen N, Nair, Suresh, Juergens, Rosalyn, Peters, Solange, Minenza, Elisa, Wrangle, John M, Rodriguez-Abreu, Delvys, Borghaei, Hossein, Blumenschein, George R, Villaruz, Liza C, Havel, Libor, Krejci, Jana, Corral Jaime, Jesus, Chang, Han, Geese, William J, Bhagavatheeswaran, Prabhu, Chen, Allen C, Socinski, Mark A
Published in The New England journal of medicine (22.06.2017)
Published in The New England journal of medicine (22.06.2017)
Get full text
Journal Article
Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
Camidge, D. Ross, Kim, Hye Ryun, Ahn, Myung-Ju, Yang, James Chih-Hsin, Han, Ji-Youn, Lee, Jong-Seok, Hochmair, Maximilian J, Li, Jacky Yu-Chung, Chang, Gee-Chen, Lee, Ki Hyeong, Gridelli, Cesare, Delmonte, Angelo, Garcia Campelo, Rosario, Kim, Dong-Wan, Bearz, Alessandra, Griesinger, Frank, Morabito, Alessandro, Felip, Enriqueta, Califano, Raffaele, Ghosh, Sharmistha, Spira, Alexander, Gettinger, Scott N, Tiseo, Marcello, Gupta, Neeraj, Haney, Jeff, Kerstein, David, Popat, Sanjay
Published in The New England journal of medicine (22.11.2018)
Published in The New England journal of medicine (22.11.2018)
Get full text
Journal Article
Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial
Shaw, Alice T, Dr, Kim, Tae Min, MD, Crinò, Lucio, Prof, Gridelli, Cesare, MD, Kiura, Katsuyuki, MD, Liu, Geoffrey, MD, Novello, Silvia, Prof, Bearz, Alessandra, MD, Gautschi, Oliver, MD, Mok, Tony, Prof, Nishio, Makoto, MD, Scagliotti, Giorgio, Prof, Spigel, David R, MD, Deudon, Stéphanie, PharmD, Zheng, Cheng, PhD, Pantano, Serafino, PhD, Urban, Patrick, MD, Massacesi, Cristian, MD, Viraswami-Appanna, Kalyanee, PhD, Felip, Enriqueta, MD
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
Fernandes Neto, João M., Nadal, Ernest, Bosdriesz, Evert, Ooft, Salo N., Farre, Lourdes, McLean, Chelsea, Klarenbeek, Sjoerd, Jurgens, Anouk, Hagen, Hannes, Wang, Liqin, Felip, Enriqueta, Martinez-Marti, Alex, Vidal, August, Voest, Emile, Wessels, Lodewyk F. A., van Tellingen, Olaf, Villanueva, Alberto, Bernards, René
Published in Nature communications (22.06.2020)
Published in Nature communications (22.06.2020)
Get full text
Journal Article
Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component
Yang, James Chih-Hsin, Ahn, Myung-Ju, Kim, Dong-Wan, Ramalingam, Suresh S, Sequist, Lecia V, Su, Wu-Chou, Kim, Sang-We, Kim, Joo-Hang, Planchard, David, Felip, Enriqueta, Blackhall, Fiona, Haggstrom, Daniel, Yoh, Kiyotaka, Novello, Silvia, Gold, Kathryn, Hirashima, Tomonori, Lin, Chia-Chi, Mann, Helen, Cantarini, Mireille, Ghiorghiu, Serban, Jänne, Pasi A
Published in Journal of clinical oncology (20.04.2017)
Published in Journal of clinical oncology (20.04.2017)
Get full text
Journal Article